Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2. (2021)

First Author: Giovannelli I
Attributed to:  A Programme for ALS Care in Europe (ALS-CarE) funded by ESRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/braincomms/fcab141

PubMed Identifier: 34409288

Publication URI: http://europepmc.org/abstract/MED/34409288

Type: Journal Article/Review

Volume: 3

Parent Publication: Brain communications

Issue: 3

ISSN: 2632-1297